Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
During your consultation, the physician will cover all the details youll need to know to ensure your treatment is easy, quick, and produces wonderful results
For neuroblastoma (NCT00002730 and NCT00005835), the therapeutic outcomes are undisclosed, and for melanoma (NCT00661336), the trial was discontinued for reasons that remain unknown
Vitiligo Research Foundation
Adquey : Acrotech expands nonsteroidal eczema control Adquey On February 12, Acrotech Biopharma won approval for Adquey (difamilast) ointment 1% for adults and pediatric patients aged 2 years and older with mild to moderate atopic dermatitis
Deciphering the mechanism of glutaredoxin-catalyzed roGFP2 redox sensing reveals a ternary complex with glutathione for protein disulfide reduction
Refyne is its softer counterpart
US$ 25.66
US$ 22.71
US$ 22.56
US$ 20.14
US$ 25.86
US$ 27.74
